[Form 4] Omeros Corporation Insider Trading Activity

Rhea-AI Filing Summary

Bank of New York Mellon Corporation (NYSE: BK) filed an 8-K on 1 July 2025 announcing two capital-return actions. First, management intends to raise the quarterly common-stock cash dividend by 13%, from $0.47 to $0.53 per share, as early as 3Q 2025, pending formal Board approval. Second, the company confirmed that the Federal Reserve has set BK’s preliminary Stress Capital Buffer (SCB) at 2.5%, the regulatory floor, for the cycle running 1 Oct 2025 through 30 Sep 2026.

The filing also reiterates that BK’s previously approved share-repurchase authorization (announced April 2024) remains in force. Repurchases may be executed via open-market, Rule 10b5-1, accelerated or other structured transactions, with size and timing governed by capital levels and market conditions.

Management notes a pending Fed proposal that would alter SCB calculation methodology and shift the effective date to 1 January, but the company currently expects no impact on its 2.5% requirement. All forward-looking statements are subject to customary risk factors and may change.

• Dividend increase: +13% to $0.53 per share (subject to Board approval).
• Capital strength: SCB remains at the regulatory minimum 2.5%.
• Ongoing buyback capacity: existing repurchase program continues.

Positive

• 13% dividend increase to $0.53 per share enhances shareholder cash returns.
• Stress Capital Buffer remains at the 2.5% floor, indicating strong capital position and lower regulatory burden.
• Existing share-repurchase authorization continues, offering additional capital-return flexibility.

Negative

• Dividend hike still contingent on Board approval, leaving a procedural risk.
• No specific buyback amount or timeline disclosed, reducing visibility into potential EPS accretion.

Insights

Banking Equity Analyst

TL;DR: 13% dividend hike and floor-level SCB underscore surplus capital; modestly accretive to yield and signals confidence.

The announced dividend lift from $0.47 to $0.53 raises the forward yield by roughly 40 bps, modestly enhancing total shareholder return without materially stressing capital ratios. Retaining the 2.5% SCB—well below money-center peers that typically range 3-4%—confirms the Fed’s view of BK’s lower risk profile, freeing incremental capital for distributions. Continuation of the April 2024 buyback authority adds tactical flexibility should shares trade below book value. No quantitative ceiling was provided, so ultimate EPS accretion will depend on execution. Overall, today’s disclosures are shareholder-friendly and signal management’s confidence in earnings resilience.

Regulatory Risk Specialist

TL;DR: Stable 2.5% SCB minimizes regulatory uncertainty; pending rule change unlikely to alter capital requirements.

The Fed’s preliminary SCB keeps BK at the statutory minimum for a sixth consecutive year, reflecting stable stress-test performance. The proposed revision to average stress-test declines and shift the effective date to 1 January could introduce timing complexities, yet management sees no impact—consistent with BK’s historically narrow capital drawdowns. Board approval remains a formality but is still required for the dividend increase. Forward-looking statements caution that market or regulatory shocks could constrain buybacks or dividends, but absent such shocks, capital distribution capacity appears intact. Net effect is low regulatory risk, supportive of valuation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Perkinson Diana T.

(Last) (First) (Middle)

201 ELLIOTT AVENUE WEST

(Street)

SEATTLE WA 98119

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OMEROS CORP [ OMER ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)(1)	$3.2	06/27/2025		A		15,000		(2)	06/27/2035	Common Stock	15,000	$0	15,000	D

Explanation of Responses:

1. Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 27, 2025.

2. This option will fully vest and become exercisable on the day before the date of the 2026 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.

	/s/ Peter B. Cancelmo, Attorney-in-Fact	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How much is BNY Mellon (BK) increasing its dividend?

13%, from $0.47 to $0.53 per share, expected to start in 3Q 2025 pending Board approval.

What is BNY Mellon's new Stress Capital Buffer requirement?

The Federal Reserve set BK’s preliminary SCB at 2.5%, effective 1 Oct 2025–30 Sep 2026.

Is BNY Mellon continuing its share-repurchase program?

Yes. The existing authorization from April 2024 remains in place, enabling purchases through various mechanisms.

Will the proposed Fed rule change affect BK's capital requirements?

Management currently does not expect the proposal to impact its 2.5% SCB requirement.

When will the dividend increase be paid if approved?

The company plans to implement the higher dividend as early as the third quarter of 2025.